These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1640777)

  • 1. Competency of human-derived Mycobacterium leprae to use palmitic acid in the synthesis of phenolic glycolipid-I and phthiocerol dimycocerosate and to release CO2 in axenic culture.
    Shannon EJ; Harris EB; Haile-Mariam HS; Guebre-Xavier M; Frommel D
    Lepr Rev; 1992 Jun; 63(2):101-7. PubMed ID: 1640777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titration of numbers of human-derived Mycobacterium leprae required to progressively oxidize 14C-palmitic acid and release 14CO2.
    Shannon EJ; Frommel D; Guebre-Xabier M; Haile-Mariam HS
    Lepr Rev; 1994 Jun; 65(2):100-5. PubMed ID: 7968182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of palmitic acid by Mycobacterium leprae in an axenic medium.
    Franzblau SG
    J Clin Microbiol; 1988 Jan; 26(1):18-21. PubMed ID: 3125213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical optima for metabolism of Mycobacterium leprae.
    Franzblau SG; Harris EB
    J Clin Microbiol; 1988 Jun; 26(6):1124-9. PubMed ID: 3290244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of Mycobacterium leprae in macrophages.
    Ramasesh N; Hastings RC; Krahenbuhl JL
    Infect Immun; 1987 May; 55(5):1203-6. PubMed ID: 3552993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phenolic glycolipid-I synthesis in extracellular Mycobacterium leprae as an indicator of antimicrobial activity.
    Harris EB; Franzblau SG; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):588-91. PubMed ID: 3065422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations into the growth of Mycobacterium leprae in a medium with palmitic acid under different gaseous environments.
    Ishaque M; Sticht-Groh V
    Microbios; 1993; 75(304):171-9. PubMed ID: 8246810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the major antigenic determinants of the characteristic phenolic glycolipid from Mycobacterium leprae.
    Brett SJ; Payne SN; Draper P; Gigg R
    Clin Exp Immunol; 1984 Apr; 56(1):89-96. PubMed ID: 6201310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of activated macrophages on Mycobacterium leprae.
    Ramasesh N; Adams LB; Franzblau SG; Krahenbuhl JL
    Infect Immun; 1991 Sep; 59(9):2864-9. PubMed ID: 1908824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy.
    Spencer JS; Brennan PJ
    Lepr Rev; 2011 Dec; 82(4):344-57. PubMed ID: 22439275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages.
    Ramasesh N; Krahenbuhl JL; Hastings RC
    Antimicrob Agents Chemother; 1989 May; 33(5):657-62. PubMed ID: 2665640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further specific extracellular phenolic glycolipid antigens and a related diacylphthiocerol from Mycobacterium leprae.
    Hunter SW; Brennan PJ
    J Biol Chem; 1983 Jun; 258(12):7556-62. PubMed ID: 6345526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diglycosyl phenol phthiocerol diester of Mycobacterium leprae.
    Daffé M; Lanéelle MA
    Biochim Biophys Acta; 1989 Apr; 1002(3):333-7. PubMed ID: 2653442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterial lipids in infected tissue samples.
    Young DB
    Ann Microbiol (Paris); 1982; 133(1):53-8. PubMed ID: 7051932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water soluble complex of palmitic acid in media for cultivation of leprosy-derived psychrophilic mycobacteria from Mycobacterium leprae infected tissues.
    Kátó L; Szejtli J; Szente L
    Acta Microbiol Hung; 1993; 40(1):47-58. PubMed ID: 8304006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular localization of Mycobacterium leprae-specific phenolic glycolipid (PGL-I) antigen in human leprosy lesions and in M. leprae isolated from armadillo liver.
    Boddingius J; Dijkman H
    J Gen Microbiol; 1990 Oct; 136(10):2001-12. PubMed ID: 2269873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.
    Verhagen C; Faber W; Klatser P; Buffing A; Naafs B; Das P
    Am J Pathol; 1999 Jun; 154(6):1793-804. PubMed ID: 10362804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial of sparfloxacin for lepromatous leprosy.
    Chan GP; Garcia-Ignacio BY; Chavez VE; Livelo JB; Jimenez CL; Parrilla ML; Franzblau SG
    Antimicrob Agents Chemother; 1994 Jan; 38(1):61-5. PubMed ID: 8141581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae.
    Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS
    FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
    Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.